IRIS
MOAVERO, ROMINA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 18.044
EU - Europa 1.176
AS - Asia 984
SA - Sud America 7
Continente sconosciuto - Info sul continente non disponibili 6
OC - Oceania 2
Totale 20.219
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 18.035
SG - Singapore 641
IE - Irlanda 240
UA - Ucraina 215
IT - Italia 185
DE - Germania 174
CN - Cina 130
KR - Corea 128
GB - Regno Unito 87
FR - Francia 78
FI - Finlandia 62
RU - Federazione Russa 38
PL - Polonia 33
TW - Taiwan 33
NL - Olanda 27
JP - Giappone 21
SE - Svezia 14
CZ - Repubblica Ceca 7
CA - Canada 6
IN - India 6
EU - Europa 5
VN - Vietnam 5
BR - Brasile 4
HK - Hong Kong 4
ES - Italia 3
AE - Emirati Arabi Uniti 2
AU - Australia 2
BE - Belgio 2
IR - Iran 2
LB - Libano 2
LK - Sri Lanka 2
MX - Messico 2
MY - Malesia 2
NO - Norvegia 2
PE - Perù 2
RO - Romania 2
SA - Arabia Saudita 2
SM - San Marino 2
TR - Turchia 2
A2 - ???statistics.table.value.countryCode.A2??? 1
BG - Bulgaria 1
CH - Svizzera 1
CL - Cile 1
CR - Costa Rica 1
CY - Cipro 1
DK - Danimarca 1
GR - Grecia 1
MO - Macao, regione amministrativa speciale della Cina 1
PT - Portogallo 1
Totale 20.219
Salva come PNG Salva come JPEG
Città #
Woodbridge 5.448
Wilmington 4.799
Houston 3.878
Fairfield 762
Singapore 563
Ann Arbor 415
Chandler 323
Seattle 312
Ashburn 303
Cambridge 239
Dublin 229
Jacksonville 184
Medford 179
Santa Clara 124
Dearborn 98
Lawrence 89
Rome 85
Beijing 63
New York 60
Menlo Park 40
Norwalk 36
Kraków 33
Taipei 33
San Diego 32
London 16
Moscow 16
Mülheim 16
Milan 14
Redwood City 13
Del Norte 11
Lappeenranta 11
Council Bluffs 9
Redmond 8
Seoul 8
University Center 8
Brno 7
Falls Church 7
Hefei 7
Mountain View 7
Saint Petersburg 7
Salt Lake City 7
Amsterdam 6
Boardman 6
Nanjing 6
Shanghai 6
Turin 6
Verona 6
Frankfurt am Main 5
Helsinki 5
Jinan 5
Kunming 5
San Mateo 5
Zhengzhou 5
Chiswick 4
Dongguan 4
Dronten 4
Nuremberg 4
Phoenix 4
Prescot 4
University Park 4
Aizu-wakamatsu Shi 3
Catania 3
Cernay 3
Chiyoda-ku 3
Fleet 3
Guangzhou 3
Hanoi 3
Indiana 3
Kilburn 3
Los Angeles 3
São Paulo 3
Tokyo 3
Beirut 2
Colombo 2
Domagnano 2
Dong Ket 2
Hangzhou 2
Hounslow 2
Hyderabad 2
Kuala Lumpur 2
Lima 2
Lugo 2
Mercer Island 2
Mondovì 2
Munich 2
Nanchang 2
Navi Mumbai 2
New Bedfont 2
Nürnberg 2
Ottawa 2
Palermo 2
Paris 2
Parma 2
Qualiano 2
Raleigh 2
Reading 2
Rende 2
San Francisco 2
San Pietro in Lama 2
Sesto San Giovanni 2
Totale 18.685
Salva come PNG Salva come JPEG
Nome #
Current role of perampanel in pediatric epilepsy 484
The Role of mTOR Inhibitors in the Treatment of Patients with Tuberous Sclerosis Complex: Evidence-based and Expert Opinions 433
Cognitive development in females with PCDH19 gene-related epilepsy 422
Neurological and neuropsychiatric aspects of tuberous sclerosis complex. 421
mTOR Inhibitors in Tuberous Sclerosis Complex. 418
Peri-ictal water drinking: a rare automatic behaviour in temporal lobe epilepsy 403
Genotype/Phenotype Correlations in Tuberous Sclerosis Complex. 395
Mammalian Target of Rapamycin Inhibitors and Life-Threatening Conditions in Tuberous Sclerosis Complex. 394
Current role of melatonin in pediatric neurology: Clinical recommendations 393
Rufinamide for the treatment of refractory epilepsy secondary to neuronal migration disorders. 391
Early onset epileptic encephalopathy or genetically determined encephalopathy with early onset epilepsy? Lessons learned from TSC 391
Reduction in retinal nerve fiber layer thickness in tuberous sclerosis complex. 385
Timing and clinical characteristics of topiramate-induced psychosis in a patient with epilepsy and tuberous sclerosis 384
Is mTOR inhibition a systemic treatment for tuberous sclerosis? 381
Long-term follow-up in children with benign convulsions associated with gastroenteritis 373
Metastatic Group 3 Medulloblastoma in a Patient With Tuberous Sclerosis Complex: Case Description and Molecular Characterization of the Tumor 371
Clinical Reasoning: A girl presenting with stiffness episodes during sleep, café-au-lait spots, and flecked retina 364
Abnormal parieto-motor connectivity in Tuberous Sclerosis Complex 363
Headache and attention deficit and hyperactivity disorder in children: common condition with complex relation and disabling consequences 360
Pancreatic neuroendocrine tumor in a child with a tuberous sclerosis complex 2 (TSC2) mutation 359
Combined targeted treatment in early onset epilepsy associated with tuberous sclerosis 359
Syndromic autism: Causes and pathogenetic pathways 358
Cognitive and behavioral effects of new antiepileptic drugs in pediatric epilepsy 358
The neurobiology of attention deficit/hyperactivity disorder. 352
Attention-deficit hyperactivity disorder (ADHD) and tuberous sclerosis complex 349
White matter disruption is associated with persistent seizures in tuberous sclerosis complex 348
The Challenge of Pharmacotherapy in Children and Adolescents with Epilepsy-ADHD Comorbidity 348
Ketogenic diet in early myoclonic encephalopathy due to non ketotic hyperglycinemia 342
Everolimus Alleviates Obstructive Hydrocephalus due to Subependymal Giant Cell Astrocytomas 342
Tubers, epileptogenic foci, and epileptogenic networks in tuberous sclerosis. 341
Autism spectrum disorders in tuberous sclerosis: pathogenetic pathways and implications for treatment. 341
Current role of rufinamide in the treatment of childhood epilepsy: literature review and treatment guidelines 340
Rufinamide efficacy and safety as adjunctive treatment in children with focal drug resistant epilepsy: The first Italian prospective study 335
MTOR inhibitors as a new therapeutic option for epilepsy 333
Paediatric use of melatonin (Author reply to D. J. Kennaway). 333
Epilepsy secondary to tuberous sclerosis: lessons learned and current challenges. 332
Attention deficit hyperactivity disorder in children with epilepsy. 328
The neurobiological basis of ADHD. 318
Long-term neurological outcome in children with early-onset epilepsy associated with tuberous sclerosis. 318
The management of subependymal giant cell tumors in tuberous sclerosis: a clinician's perspective 318
Early control of seizures improves long-term outcome in children with tuberous sclerosis complex. 317
Can we change the course of epilepsy in tuberous sclerosis complex? 297
Management of epilepsy associated with tuberous sclerosis complex (TSC): clinical recommendations. 297
Syndrome of Transient Headache and Neurologic Deficits With Cerebrospinal Fluid Lymphocitosis Should Be Considered in Children Presenting With Acute Confusional State 295
Risk and Protective Environmental Factors Associated with Autism Spectrum Disorder: Evidence-Based Principles and Recommendations 292
New perspectives in Autism spectrum disorder associated with tuberous sclerosis 277
Vagus nerve stimulation for refractory epilepsy in tuberous sclerosis. 275
Pharmacotherapy of idiopathic generalized epilepsies 269
Neuroimaging findings of Sturge-Weber Syndrome in a child with Tuberous Sclerosis 261
Safety and tolerability profile of new antiepileptic drug treatment in children with epilepsy 252
Management of epilepsy associated with tuberous sclerosis complex: Updated clinical recommendations 248
Recent advances in neurobiology of Tuberous Sclerosis Complex 237
A clinical update on tuberous sclerosis complex-associated neuropsychiatric disorders (TAND) 184
mTOR dysregulation and tuberous sclerosis-related epilepsy 154
Everolimus for Retinal Astrocytic Hamartomas in Tuberous Sclerosis Complex 136
A step-wise approach for establishing a multidisciplinary team for the management of tuberous sclerosis complex: A Delphi consensus report 127
Early Clinical Predictors of Autism Spectrum Disorder in Infants with Tuberous Sclerosis Complex: Results from the EPISTOP Study 121
Cyclic vomiting syndrome and benign paroxysmal torticollis are associated with a high risk of developing primary headache: A longitudinal study 117
Clinical Features of Pediatric Idiopathic Intracranial Hypertension and Applicability of New ICHD-3 Criteria 116
Immediate and prolonged-release melatonin in children with neurodevelopmental disabilities. Author reply to Prof. Zisapel 113
Features of primary chronic headache in children and adolescents and validity of ICHD 3 criteria 110
Prophylactic treatment of pediatric migraine: Is there anything new in the last decade? 108
Risk and Protective Environmental Factors Associated with Autism Spectrum Disorder: Evidence-Based Principles and Recommendations 96
Tolerability of palmitoylethanolamide in a pediatric population suffering from migraine: a pilot study 89
Is autism driven by epilepsy in infants with Tuberous Sclerosis Complex? 74
Anxiety, Depression, and Body Weight in Children and Adolescents With Migraine 55
Benign Intracranial Hypertension Due to Hypoparathyroidism: A Case Report 48
Sleep Disorders in Pediatric Migraine: A Questionnaire-Based Study 45
Sleep disorders and neuropsychiatric disorders in a pediatric sample of tuberous sclerosis complex: a questionnaire-based study 40
Case Report: Migralepsy: The Two-Faced Janus of Neurology 40
High Intellectual Potential and High Functioning Autism: Clinical and Neurophysiological Features in a Pediatric Sample 35
Pediatric Neuromyelitis Optica Spectrum Disorder: Case Series and Literature Review 34
Autism and Epilepsy in Patients With Tuberous Sclerosis Complex 33
Event-Related Potentials in ADHD Associated With Tuberous Sclerosis Complex: A Possible Biomarker of Symptoms Severity? 32
Subacute Sclerosing Panencephalitis in Children: The Archetype of Non-Vaccination 31
Early epileptiform EEG activity in infants with tuberous sclerosis complex predicts epilepsy and neurodevelopmental outcomes 29
Screen exposure and sleep: How the COVID-19 pandemic influenced children and adolescents - A questionnaire-based study 28
Neuropsychological Sequelae, Quality of Life and Adaptive Behavior in Children and Adolescents with Anti-NMDAR Encephalitis: A Narrative Review 28
I stay at home with headache. A survey to investigate how the lockdown for COVID-19 impacted on headache in Italian children 28
Prevention of Epilepsy in Infants with Tuberous Sclerosis Complex in the EPISTOP Trial 26
Safety of SARS-CoV2 vaccination and COVID-19 short-term outcome in pediatric acquired demyelinating disorders of central nervous system: A single center experience 25
Primary Headaches and Sleep Disorders: Review of Literature about Comorbidity in Children and Adolescents 25
Truths and Myths in Pediatric Migraine and Nutrition 25
Surgery for drug-resistant tuberous sclerosis complex-associated epilepsy: who, when, and what 25
Long-Term Effects of COVID-19 Pandemic on Migraine in Adolescents. A Retrospective Analysis of the Population Attending the Headache Center in Different Phases of the Pandemic 24
Diagnosis of pediatric anti-NMDAR encephalitis at the onset: A clinical challenge 22
Questionnaire-based assessment of sleep disorders in an adult population of Tuberous Sclerosis Complex 21
Long-term use of {mTORC}1 inhibitors in tuberous sclerosis complex associated neurological aspects 21
How to Assess the Headache—Sleep Disorders Comorbidity in Children and Adolescents 21
Medication Overuse Withdrawal in Children and Adolescents Does Not Always Improve Headache: A Cross-Sectional Study 21
Sleep disturbances and behavioral symptoms in pediatric Sotos syndrome 20
Migraine and Its Equivalents: What Do They Share? A Narrative Review on Common Pathophysiological Patterns 20
Case report: A pediatric case of Bickerstaff brainstem encephalitis after COVID-19 vaccination and Mycoplasma pneumoniae infection: Looking for the culprit 19
Features and Management of New Daily Persistent Headache in Developmental-Age Patients 18
Restless sleep disorder in a sample of children and adolescents with autism spectrum disorder: preliminary results from a case series 17
Interictal Cognitive Performance in Children and Adolescents With Primary Headache: A Narrative Review 16
Use of Nutraceutical Ingredient Combinations in the Management of Tension-Type Headaches with or without Sleep Disorders 16
Molecular EPISTOP, a comprehensive multi-omic analysis of blood from Tuberous Sclerosis Complex infants age birth to two years 16
Prediction of Neurodevelopment in Infants With Tuberous Sclerosis Complex Using Early EEG Characteristics 15
Genetic pathogenesis of the epileptogenic lesions in Tuberous Sclerosis Complex: Therapeutic targeting of the mTOR pathway 15
Totale 20.474
Salva come PNG Salva come JPEG
Categoria #
all - tutte 46.715
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 46.715
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20203.868 0 0 0 505 432 510 407 449 440 386 358 381
2020/20213.243 348 394 391 419 273 402 400 283 68 89 142 34
2021/2022741 33 54 28 10 22 62 26 21 159 54 54 218
2022/2023867 97 90 18 82 82 236 88 36 69 3 41 25
2023/2024418 43 9 21 3 28 97 8 3 3 17 98 88
2024/20251.108 57 672 359 20 0 0 0 0 0 0 0 0
Totale 20.516